This article is more than 5 years old. Information may no longer be current.

Genetic test for Avellino corneal dystrophy launched

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Avellino-Gene Detection System has been launched in the U.S. to help patients and physicians make a more informed decision before going forward with vision correction surgery, including LASIK, LASEK and PRK, according to a news release from Avellino Lab USA.

The test can determine whether patients carry the Avellino corneal dystrophy gene mutation that puts them at higher risk for the disease, which causes corneal opacity and potential blindness, the release said. Laser surgery can exacerbate the problem, according to the company’s website.

The test is conducted with a swab from inside the patient’s mouth that is sent to Avellino Lab USA. Results are sent to the ophthalmologist in about 48 hours, the release said.

There is no treatment for Avellino corneal dystrophy, also known as granular corneal dystrophy type 2.